Promoter and functional polymorphisms of HTR2C and suicide victims

Genes, Brain and Behavior

Volumn 8, Issue 5, 2009, Pages 541-545

  Videtič, Alja ^a   Peternelj, Tina T ^a   Zupanc, Tomaž ^a   Balažic, Jože ^a   Komel, Radovan ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

995G>A; 68G>C; Case control study; Haplotype; Serotonin receptor 2C; Slavic Slovenian population

Indexed keywords

CYSTEINE; CYTOSINE; GUANINE; SERINE; SEROTONIN 2C RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HTR2C GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEROTONINERGIC SYSTEM; SLOVENIA; SUICIDE;

ADULT; AGED; BRAIN; BRAIN CHEMISTRY; DEPRESSIVE DISORDER; DNA MUTATIONAL ANALYSIS; EUROPE, EASTERN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SEX CHARACTERISTICS; SLOVENIA; SUICIDE;

EID: 67650484047     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2009.00505.x     Document Type: Article

References (32)

1. Andolfatto, P. & Nordborg M. (1998) The effect of gene conversion on intralocus associations. Genetics 148, 1397 1399.
2. Asberg, M., Traskman L. & Thoren P. (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33, 1193 1197.
3. Barrett, J.C., Fry B., Maller J. & Daly M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263 265. (Pubitemid 40202029)
4. Biver, F., Lotstra F., Monclus M., Wikler D., Damhaut P., Mendlewicz J. & Goldman S. (1996) Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett 204, 25 28.
5. Bondy, B., Buettner A. & Zill P. (2006) Genetics of suicide. Mol Psychiatry 11, 336 351.
6. Brezo, J., Klempan T. & Turecki G. (2008) The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am 31, 179 203. (Pubitemid 351551424)
7. Cremers, T.I., Rea K., Bosker F.J., Wikstrom H.V., Hogg S., Mork A. & Westerink B.H. (2007) Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology 32, 1550 1557. (Pubitemid 46920163)
8. Eltayb, A., Wadenberg M.L., Schilstrom B. & Svensson T.H. (2007) Antipsychotic-like effect by combined treatment with citalopram and WAY 100635: involvement of the 5-HT2C receptor. Int J Neuropsychopharmacol 10, 405 410.
9. Evans, J., Reeves B., Platt H., Leibenau A., Goldman D., Jefferson K. & Nutt D. (2000) Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30, 1327 1334. (Pubitemid 30831015)
10. Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39, 175 191.
11. Fehr, C., Szegedi A., Anghelescu I., Klawe C., Hiemke C. & Dahmen N. (2000) Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr Genet 10, 59 65. (Pubitemid 32000901)
12. Kirkman, T.W. (1996) Statistists to Use. http://www.physics.-csbsju.edu/ stats/.
13. Kumar, H.B., Purushottam M., Kubendran S., Gayathri P., Mukherjee O., Murthy A.R., Ghosh S., Chandra P., Reddy Y.C., Benegal V., Brahmachari S.K. & Jain S. (2007) Serotonergic candidate genes and puerperal psychosis: an association study. Psychiatr Genet 17, 253 260. (Pubitemid 47345746)
14. Lappalainen, J., Long J.C., Virkkunen M., Ozaki N., Goldman D. & Linnoila M. (1999) HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biol Psychiatry 46, 821 826. (Pubitemid 29460909)
15. Lappalainen, J., Zhang L., Dean M., Oz M., Ozaki N., Yu D.H., Virkkunen M., Weight F., Linnoila M. & Goldman D. (1995) Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 27, 274 279.
16. Lerer, B., Macciardi F., Segman R.H., et al. (2001) Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 6, 579 585. (Pubitemid 32772567)
17. Marusic, A. (2005) History and geography of suicide: could genetic risk factors account for the variation in suicide rates? Am J Med Genet C Semin Med Genet 133C, 43 47. (Pubitemid 40194128)
18. McCarthy, S., Mottagui-Tabar S., Mizuno Y., Sennblad B., Hoffstedt J., Arner P., Wahlestedt C. & Andersson B. (2005) Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin. Hum Genet 117, 545 557. (Pubitemid 41535576)
19. Okada, M., Northup J.K., Ozaki N., Russell J.T., Linnoila M. & Goldman D. (2004) Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry 9, 55 64. (Pubitemid 38175082)
20. Pandey, G.N., Dwivedi Y., Ren X., Rizavi H.S., Faludi G., Sarosi A. & Palkovits M. (2006) Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res 31, 167 176.
21. Pooley, E.C., Houston K., Hawton K. & Harrison P.J. (2003) Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychol Med 33, 775 783. (Pubitemid 36874657)
22. Raymond, J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S. & Garnovskaya M.N. (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92, 179 212. (Pubitemid 34251133)
23. Ribases, M., Fernandez-Aranda F., Gratacos M., Mercader J.M., Casasnovas C., Nunez A., Vallejo J. & Estivill X. (2008) Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. J Psychiatr Res 42, 50 57. (Pubitemid 47562431)
24. Serretti, A., Calati R., Giegling I., Hartmann A.M., Moller H.J. & Rujescu D. (2009) Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls. J Psychiatr Res 43, 519 525.
25. Serretti, A., Mandelli L., Giegling I., Schneider B., Hartmann A.M., Schnabel A., Maurer K., Moller H.J. & Rujescu D. (2007) HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet 144B, 291 299. (Pubitemid 46642017)
26. Stefulj, J., Buttner A., Kubat M., Zill P., Balija M., Eisenmenger W., Bondy B. & Jernej B. (2004) 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 254, 224 227. (Pubitemid 39312834)
27. Tregouet, D.A. & Garelle V. (2007) A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23, 1038 1039. (Pubitemid 47050595)
28. Turecki, G., Sequeira A., Gingras Y., Seguin M., Lesage A., Tousignant M., Chawky N., Vanier C., Lipp O., Benkelfat C. & Rouleau G.A. (2003) Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet B Neuropsychiatr Genet 118, 36 40. (Pubitemid 37064073)
29. Wilffert, B., Zaal R. & Brouwers J.R. (2005) Pharmacogenetics as a tool in the therapy of schizophrenia. Pharm World Sci 27, 20 30. (Pubitemid 40362673)
30. Xie, E., Zhu L., Zhao L. & Chang L.S. (1996) The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant. Genomics 35, 551 561. (Pubitemid 26270023)
31. Zhang, J., Shen Y., He G., Li X., Meng J., Guo S., Li H., Gu N., Feng G. & He L. (2008) Lack of association between three serotonin genes and suicidal behavior in Chinese psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry 32, 467 471. (Pubitemid 351178965)
32. World Health Organization (2008) Mental Health, Suicide prevention and special programmes, Country reports and charts available, Geneva.